Holen Sie sich die Stockscreener-App
311.43
2.54%
-8.12
Handel nachbörslich:
311.43
Schlusskurs vom Vortag:
$319.55
Offen:
$317.04
24-Stunden-Volumen:
252.59K
Relative Volume:
1.00
Marktkapitalisierung:
$6.85B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-11.40
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
-7.35%
1M Leistung:
+1.94%
6M Leistung:
+31.77%
1J Leistung:
-15.47%
1-Tages-Spanne:
$308.36
$319.85
1-Wochen-Bereich:
$298.22
$340.68
52-Wochen-Spanne:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
311.43 | 8.62B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Using R and stats models for Bio Rad Laboratories Inc. forecastingWeekly Investment Recap & Step-by-Step Swing Trade Plans - newser.com
Is Bio Rad Laboratories Inc. forming a bottoming baseJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
What macro factors could drive Bio Rad Laboratories Inc. Class stock higherJuly 2025 Snapshot & Target Return Focused Picks - newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 daysJuly 2025 Catalysts & Reliable Price Action Trade Plans - newser.com
Is Bio Rad Laboratories Inc. Class B stock a buy before new product rollout2025 Top Gainers & Community Verified Trade Signals - newser.com
Assetmark Inc. Buys 12,023 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
HbA1c Testing Market Research Report 2025-2033, Profiles of - GlobeNewswire
HbA1c Testing Market Research Report 2025-2033, Profiles of Key PlayersDanaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics - Yahoo Finance
How Bio Rad Laboratories Inc. (BUW) stock stacks up against competitorsPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Will Bio Rad Laboratories Inc. Class B stock deliver stable dividends2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buyTake Profit & Weekly High Return Forecasts - newser.com
Is Bio Rad Laboratories Inc. meeting your algorithmic filter criteria2025 Retail Activity & Accurate Buy Signal Notifications - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. Class stockMarket Growth Report & Stepwise Trade Signal Implementation - newser.com
How Bio Rad Laboratories Inc. Class B stock responds to bond marketSwing Trade & Free Reliable Trade Execution Plans - newser.com
Understanding Bio Rad Laboratories Inc.’s price movementQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
What market sentiment indicators show for Bio Rad Laboratories Inc. (BUWA) stock2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - newser.com
Is Bio Rad Laboratories Inc. stock poised for growthPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO? - Yahoo Finance
Bio Rad Laboratories Inc. stock trend forecast2025 Year in Review & Smart Allocation Stock Reports - newser.com
Will Bio Rad Laboratories Inc. outperform the marketMarket Trend Report & Growth Focused Entry Reports - newser.com
Assessing Bio-Rad Laboratories’s Valuation After Posting a Sharp Quarterly Net Loss Despite Stable Sales - Sahm
Is Bio-Rad (BIO) Sending a New Signal With Expanded Buybacks and Diagnostic Partnerships? - simplywall.st
How Bio Rad Laboratories Inc. (BUW) stock reacts to weak economyPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
How to build a dashboard for Bio Rad Laboratories Inc. stockDay Trade & Weekly Top Stock Performers List - newser.com
Will Bio Rad Laboratories Inc. stock recover after recent dropPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com
Will Bio Rad Laboratories Inc. Class stock sustain bullish trend into 2025Gap Up & Entry Point Strategy Guides - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock beat Nasdaq index returns2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
GAM Holding AG Acquires New Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
What technical charts say about Bio Rad Laboratories Inc. stockEarnings Overview Report & Safe Entry Point Identification - newser.com
Wall Street Zen Upgrades Bio-Rad Laboratories (NYSE:BIO) to Buy - MarketBeat
Is Bio Rad Laboratories Inc. stock a bargain at current levelsJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - newser.com
Will Bio Rad Laboratories Inc. Class stock outperform value peersWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Stock Holdings Increased by State of New Jersey Common Pension Fund D - MarketBeat
Can Bio Rad Laboratories Inc. stock sustain revenue growth2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
What valuation multiples suggest for Bio Rad Laboratories Inc. stockDollar Strength & Verified Chart Pattern Trade Signals - newser.com
What recovery options are there for Bio Rad Laboratories Inc.July 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Bio-Rad Laboratories (NYSE:BIO) Given New $375.00 Price Target at Citigroup - MarketBeat
Weiss Ratings Upgrades Bio-Rad Laboratories (NYSE:BIO) to Hold (C-) - MarketBeat
Wells Fargo & Company Raises Bio-Rad Laboratories (NYSE:BIO) Price Target to $340.00 - MarketBeat
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):